Beneish M-Score

The following section summarizes insights on 's Beneish M-Score:

• Pfizer's latest twelve months enterprise value (ev) is 166.9 billion
• Pfizer's enterprise value (ev) for fiscal years ending December 2020 to 2024 averaged 210.6 billion.
• Pfizer's operated at median enterprise value (ev) of 195.1 billion from fiscal years ending December 2020 to 2024.
• Looking back at the last 5 years, Pfizer's enterprise value (ev) peaked in December 2021 at 281.4 billion.
• Pfizer's enterprise value (ev) hit its 5-year low in December 2023 of 152.8 billion.
• Pfizer's enterprise value (ev) decreased in 2020 (195.1 billion, -9.8%), 2022 (256.7 billion, -8.8%), and 2023 (152.8 billion, -40.5%) and increased in 2021 (281.4 billion, +44.2%) and 2024 (166.9 billion, +9.2%).